Angiographic Embolotherapy is An Effective Treatment for Blunt Splenic Injuries with Active Hemorrhage or Transient Response to Fluid Resuscitation

Chen-Chih huang,Li-Jen Wang,Y. Wong,Cheng-Hsien Wu,Y. Liu,C. Fu,Huan-Wu Chen,Jen-Feng Fang

2008-03-01

Abstract:Patients of blunt splenic injuries who had CT findings of active hemorrhage or transient response to fluid resuscitation were referred for angiographic embolotherapy. The purpose of this retrospective study was to determine the effectiveness, complications, and final outcome of different types of embolotherapy. The charts of 30 consecutive adult patients who received spleen embolotherapy from January 2001 to December 2004 were reviewed. One patient of multiple trauma died during embolotherapy was excluded. Of the remaining 29 patients, 9 (31.0%) underwent superselective branch-artery alone embolotherapy, 17 (58.6%) main-artery alone embolotherapy, 3 (10.4%) both branch- and main-artery embolotherapy. A continuous drop of hemoglobin occurred in 2 (6.9%) patients. Splenic abscess developed in 2 (6.9%) patients. None of the 29 patients died of spleen-related hemorrhage. For patients accepted branch-artery alone embolotherapy, the odds ratios of having a post-embolotherapy event were 2.00 (95% CI: 0.11, 36.31), when compared with patients accepted main-artery alone embolotherapy. The ratios were all 2.38 (95% CI: 0.13, 42.83) for patients with branch-artery alone embolotherapy, when compared with patients who were not treated with branch-artery embolotherapy alone. In conclusion, the association between risk factors (effectiveness, complications, outcomes) and types of embolotherapy had no statistical significance, however, it seemed that people who accepted branch-artery alone embolotherapy had a higher risk of complications than people accepted main-artery embolotherapy.